Up a level |
Puyade, Mathieu, Patel, Amit, Lim, Yeong Jer, Blank, Norbert, Badoglio, Manuela, Gualandi, Francesca, Ma, David D, Maximova, Natalia, Greco, Raffaella, Alexander, Tobias et al (show 1 more authors)
(2021)
Autologous Hematopoietic Stem Cell Transplantation for Behcet's Disease: A Retrospective Survey of Patients Treated in Europe, on Behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation.
, Switzerland.
Brittain, Gavin, Petrie, Jennifer, Duffy, Kate EM, Glover, Rachel, Hullock, Katie, Papaioannou, Diana, Roldan, Elisa, Beecher, Colette, Bursnall, Matthew, Ciccarelli, Olga et al (show 19 more authors)
(2024)
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
BMJ open, 14 (2).
e083582-e083582.
Barnes, Eleanor, Goodyear, Carl S, Willicombe, Michelle, Gaskell, Charlotte, Siebert, Stefan, de Silva, Thushan I, Murray, Sam M, Rea, Daniel, Snowden, John A, Carroll, Miles et al (show 37 more authors)
(2023)
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease.
NATURE MEDICINE, 29 (7).
1760-+.